Edward H. Eiland

795 total citations
20 papers, 374 citations indexed

About

Edward H. Eiland is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Edward H. Eiland has authored 20 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Applied Microbiology and Biotechnology, 8 papers in Infectious Diseases and 8 papers in Clinical Biochemistry. Recurrent topics in Edward H. Eiland's work include Antibiotic Use and Resistance (9 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Edward H. Eiland is often cited by papers focused on Antibiotic Use and Resistance (9 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Edward H. Eiland collaborates with scholars based in United States and United Kingdom. Edward H. Eiland's co-authors include Thomas M. English, Lea S. Eiland, Raymond A. Lorenz, Kurt A. Wargo, Jerod Nagel, Keith S. Kaye, James G. Stevenson, Patrick M. McDaneld, Daryl D. DePestel and Christopher J. Destache and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and American Journal of Kidney Diseases.

In The Last Decade

Edward H. Eiland

17 papers receiving 361 citations

Peers

Countries citing papers authored by Edward H. Eiland

Since Specialization

Citations

This map shows the geographic impact of Edward H. Eiland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward H. Eiland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward H. Eiland more than expected).

Fields of papers citing papers by Edward H. Eiland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward H. Eiland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward H. Eiland. The network helps show where Edward H. Eiland may publish in the future.

Co-authorship network of co-authors of Edward H. Eiland

This figure shows the co-authorship network connecting the top 25 collaborators of Edward H. Eiland. A scholar is included among the top collaborators of Edward H. Eiland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward H. Eiland. Edward H. Eiland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improvements in Automated Continuous Measurement of Drilling Fluid Properties 2017 ·SPE Kingdom of Saudi Arabia Annual Technical Symposium and Exhibition ·(unknown), (unknown), Sandeep D. Kulkarni, (unknown), Edward H. Eiland	10
2	Demonstrating the Value of Antimicrobial Stewardship Programs to Hospital Administrators 2014 ·Clinical Infectious Diseases ·Jerod Nagel, James G. Stevenson, Edward H. Eiland, Keith S. Kaye	37
3	Assessing Appropriateness of Antimicrobial Therapy: In the Eye of the Interpreter 2014 ·Clinical Infectious Diseases ·Daryl D. DePestel, Edward H. Eiland, Katherine Lusardi, Christopher J. Destache, (unknown), Patrick M. McDaneld, Kenneth C. Lamp, (unknown), Elizabeth D. Hermsen	38
4	Linezolid-Induced Lactic Acidosis Corrected With Sustained Low-Efficiency Dialysis: A Case Report 2014 ·American Journal of Kidney Diseases ·(unknown), Heather-Lyn Haley, (unknown), (unknown), Edward H. Eiland	11
5	Fidaxomicin Use and Clinical Outcomes for Clostridium difficile–Associated Diarrhea 2014 ·Infectious Diseases in Clinical Practice ·Edward H. Eiland, (unknown), (unknown)	14
6	Breaking Down the Barriers: Challenges With Development and Implementation of an Industry-Sponsored Antimicrobial Stewardship Data Collection and Analysis Tool 2014 ·Clinical Infectious Diseases ·Elizabeth D. Hermsen, Patrick M. McDaneld, Edward H. Eiland, Christopher J. Destache, Katherine Lusardi, (unknown), (unknown), Daryl D. DePestel, Kenneth C. Lamp, (unknown), (unknown), Peggy S. McKinnon	2
7	Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence‐Based Support from the Medical Literature 2013 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), Edward H. Eiland, Raymond A. Lorenz	66
8	Activities of aClostridium difficileinfection reduction team 2011 ·American Journal of Health-System Pharmacy ·Edward H. Eiland	2
9	Assessment of Vancomycin Dosing and Subsequent Serum Concentrations in Pediatric Patients 2011 ·Annals of Pharmacotherapy ·Lea S. Eiland, Thomas M. English, Edward H. Eiland	87
10	The Utility of Rapid Microbiological and Molecular Techniques in Optimizing Antimicrobial Therapy 2010 ·Edward H. Eiland, Nicholas D. Beyda, Jian Han, (unknown), (unknown), Thomas M. English, Ali Hassoun, (unknown)	2
11	Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-ResistantStaphylococcus aureusComplicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid 2010 ·SHILAP Revista de lepidopterología ·(unknown), Edward H. Eiland	9
12	Ceftobiprole: A Novel Broad-Spectrum Antiinfective 2008 ·Journal of Pharmacy Technology ·(unknown), Edward H. Eiland	0
13	Pitfalls Associated With Antibiograms 2008 ·Journal of Pharmacy Practice ·Edward H. Eiland, (unknown), (unknown)	0
14	Current Perspectives on Extended-Spectrum Beta-Lactamase–Producing Gram-Negative Bacilli 2008 ·Journal of Pharmacy Practice ·(unknown), Edward H. Eiland	2
15	Forecast of Antibiotic Development in an Era of Increasing Bacterial Resistance 2008 ·Journal of Pharmacy Practice ·Edward H. Eiland, (unknown)	4
16	Zanamivir for the prevention of influenza in adults and children age 5 years and older. 2007 ·PubMed ·Lea S. Eiland, Edward H. Eiland	19
17	Analysis of adherence to national nosocomial pneumonia treatment guidelines. 2007 ·PubMed ·Edward H. Eiland, Kurt A. Wargo, (unknown), Ali Hassoun	8
18	Effect of linezolid on the occurrence of vancomycin-resistant enterococci 2007 ·American Journal of Health-System Pharmacy ·Edward H. Eiland, Jennifer B. Robinson	1
19	Comparison of the Modification of Diet in Renal Disease and Cockcroft–Gault Equations for Antimicrobial Dosage Adjustments 2006 ·Annals of Pharmacotherapy ·Kurt A. Wargo, Edward H. Eiland, (unknown), Thomas M. English, (unknown)	59
20	Maximizing Pharmacodynamics with High-Dose Levofloxacin 2005 ·Hospital Pharmacy ·Kurt A. Wargo, (unknown), Edward H. Eiland	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact